OraSure Technologies, Inc. (OSUR) has a MoatMap StockRank of 78/100 based on Quality (40/100), Value (46/100), and Momentum (75/100) factor scores. The current signal is BUY. OraSure Technologies specializes in point-of-care diagnostics. Following the post-pandemic decline in COVID-19 testing revenues, the company lacks a high-margin, scalable product suite or a clear path to compounding returns within our target themes.
OraSure Technologies, Inc. develops, manufactures, and markets a broad range of diagnostic products and collection devices, primarily focused on oral fluid technology for infectious diseases like HIV and COVID-19, and substance abuse. The company holds a competitive edge through its proprietary oral fluid collection platforms and established market presence in point-of-care diagnostics, catering to both clinical and consumer markets.
| Price | $4.24 |
| Market Cap | $291M |
| P/E (Forward) | -8.29 |
| Price/Book | 0.86 |
| Return on Equity | -21.2% |
| Return on Invested Capital | -18.7% |
| Debt/Equity | 4.04 |
| Gross Margin | 42.3% |
| Operating Margin | -78.4% |
| Revenue Growth | -6.7% |
| Free Cash Flow | $-9M |
OraSure Technologies, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).